Zynext Ventures Invests in Illexcor Therapeutics to Advance Next-Generation Oral Treatment for Sickle Cell Disease

 Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), announced its investment in Illexcor Ther...

March 13, 2025 | Thursday | News
UCB Announces Long-Term Efficacy and Safety Findings of FINTEPLA® for Dravet Syndrome, Published in Epilepsia

UCB, a global biopharmaceutical company, announced that Epilepsia published findings from the final analysis of the long-term open-label extension (OLE) st...

March 13, 2025 | Thursday | News
GC Cell Launches Phase 1 Clinical Trial for GCC2005, a Novel CD5 CAR-NK Therapy Targeting T-Cell Lymphomas

GC Cell, under the leadership of CEO Sungyong Won, announced the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205), a novel CD5...

March 13, 2025 | Thursday | News
Gilead Presents Promising Phase 1 Data for Once-Yearly Lenacapavir as HIV Pre-Exposure Prophylaxis

Gilead Sciences, Inc. presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of lenacapavir, the company...

March 12, 2025 | Wednesday | News
Merck ( MSD ) Opens $1 Billion Vaccine Manufacturing Facility in Durham, North Carolina

Merck, known as MSD outside of the United States and Canada, announced  the opening of a new, $1 billion, 225,000-square-foot facility dedicated to va...

March 12, 2025 | Wednesday | News
CervoMed Reports Positive 16-Week Extension Results for Neflamapimod in Lewy Body Dementia

CervoMed Inc. a clinical-stage company focused on developing treatments for age-related neurologic disorders (CervoMed or the Company), announced positive ...

March 11, 2025 | Tuesday | News
Optimizing Drug Launch Strategies with DelveInsight for Primary Immunodeficiency Therapies

To gain a competitive edge, the company partnered with DelveInsight to analyze competitor launch timelines, first-to-market companies, ...

March 11, 2025 | Tuesday | News
Aragen Strengthens Leadership with Key Appointments in Drug Discovery and Chemical Development

Aragen, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced two senior level appointments. Dr. Manjunath Rama...

March 10, 2025 | Monday | News
Bristol Myers Squibb Reports Positive Phase 3 Data for Sotyktu in Psoriatic Arthritis

 Bristol Myers Squibb  announced positive data from the pivotal Phase 3 POETYK PsA-2 trial (IM011-055) evaluating the efficacy and safety of ...

March 10, 2025 | Monday | News
Roche Opens Genentech Innovation Center in Boston, Expands Harvard R&D and AI Collaboration

Roche  announced  the launch of the Roche Genentech Innovation Center Boston at Harvard’s Enterprise Research Campus in Allston which will ...

March 10, 2025 | Monday | News
Johnson & Johnson Reports Promising Phase 3 Data for Icotrokinra in Plaque Psoriasis, Launches Head-to-Head Study

Johnson & Johnson announced new icotrokinra (JNJ-2113) data from its comprehensive Phase 3 clinical program and the start of the first-ever head-t...

March 10, 2025 | Monday | News
Akeso’s Ivonescimab Phase III Study Results Published in The Lancet, Paving the Way for New NSCLC Treatment

Akeso, Inc. is excited to announce that the groundbreaking results of the Phase III clinical study (HARMONi-2/AK112-303) of its first-in-class PD-1/VE...

March 07, 2025 | Friday | News
Nona Biosciences Unveils AI-Assisted Hu-mAtrIx™ Platform to Revolutionize Antibody Discovery

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM),  announced to unveil its innovative AI-...

March 07, 2025 | Friday | News
iTeos Therapeutics Reports Strong 2024 Financial Results and Strategic Update for 2025

iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology treatm...

March 07, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close